/
RSS Feed
CHRISTIAN SPAULDING, Cochin Hospital, Paris
REFERENCE: N Engl J Med 2006;355:1093, 1105,1169
Two leading articles in the same edition of the New England Journal of Medicine have investigated the use of drug-eluting stents in primary percutaneous coronary intevention in comparison with bare-metal stents. A group from Paris looked at the sirolimus-eluting stent, while a second group from Amsterdam investigated the paclitaxel-eluting stent. Sarah Maxwell talked with Christian Spaulding whose results showed an improvement in rates of target vessel revascularisation.
[audio:https://www.audiomedica.com/podcasting/cardio/061008ChristianSpaulding.mp3]
Two leading articles in the same edition of the New England Journal of Medicine have investigated the use of drug-eluting stents in primary percutaneous coronary intevention in comparison with bare-metal stents. A group from Paris looked at the sirolimus-eluting stent, while a second group from Amsterdam investigated the paclitaxel-eluting stent. Sarah Maxwell talked with Christian Spaulding whose results showed an improvement in rates of target vessel revascularisation.
